T 1 ‐weighted fMRI in mouse visual cortex using an iron oxide nanoparticle contrast agent and UTE imaging at 9.4 T
Magnetic Resonance in Medicine · 2026
DOI: 10.1002/mrm.70103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2026. Verfasst von Naman Jain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Brain Institute, The University of Queensland, St Lucia, Queensland, Australia. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Visual Cortex, Magnetic Iron Oxide Nanoparticles, Magnetite Nanoparticles. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIMH NIH HHS, National Health and Medical Research Council.
Abstract (Originalsprache)
Purpose
This study aims to investigate the feasibility of using T 1 ‐weighted fMRI with an iron oxide nanoparticle contrast agent and UTE imaging at 9.4 T to measure functional hyperemia in the mouse visual cortex. The goal is to capture positive signal changes in both the parenchyma and pial surface, and to test whether surface vessels respond during neuronal activation.
Method
The study involved scanning of nine mice after administration of iron oxide–based superparamagnetic contrast agent via the tail vein. Two functional imaging experiments were conducted: one to investigate the effect of TE on the functional response, and another to characterize the impact of higher resolution on UTE functional contrast. Regions of interest were defined in the parenchyma and pial surface of the visual cortex.
Results
The administration of the contrast agent produced a bright‐blood signal in the vasculature in structural MRI when using a UTE acquisition. Positive signal changes were observed at the shortest TE (0.164 ms) in voxels sampling both the parenchyma (0.22% ± 0.08%) and pial surface (0.26% ± 0.1%), providing evidence that UTE fMRI experiments can detect changes in both parenchymal and pial vessels. Measurements using longer TEs (≥1 ms) showed negative signal changes, as expected. Higher spatial resolution resulted in increased percent signal change at the pial surface, suggesting reduced partial volume effects.
Conclusion
The findings demonstrate that T 1 ‐weighted fMRI with UTE imaging and Superparamagnetic Iron Oxide nanoparticles captures positive signal changes across all vascular compartments, providing additional insights into the involvement of surface vessels during functional hyperemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Queensland Brain Institute, The University of Queensland, St Lucia, Queensland, Australia.
- Centre for Advanced Imaging, The University of Queensland, St Lucia, Queensland, Australia.
- School of Electrical Engineering and Computer Science, The University of Queensland, St Lucia, Queensland, Australia.
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
- Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA.
- Harvard-MIT Program in Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
ORCID-Profile: Naman Jain, Saskia Bollmann, Kai-Hsiang Chuang, Jonathan R Polimeni, Markus Barth
Förderung
- NIBIB NIH HHS
- NIMH NIH HHS
- National Health and Medical Research Council
- BRAIN Initiative
Zitieren
APA
Jain, N., Bollmann, S., Chuang, K. H., Polimeni, J. R., & Barth, M. (2026). T 1 ‐weighted fMRI in mouse visual cortex using an iron oxide nanoparticle contrast agent and UTE imaging at 9.4 T. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.70103
Vancouver
Jain N, Bollmann S, Chuang KH, Polimeni JR, Barth M. T 1 ‐weighted fMRI in mouse visual cortex using an iron oxide nanoparticle contrast agent and UTE imaging at 9.4 T. Magnetic Resonance in Medicine. 2026. doi:10.1002/mrm.70103
BibTeX
@article{Jain2026,
author = {Jain, Naman and Bollmann, Saskia and Chuang, Kai-Hsiang and Polimeni, Jonathan R and Barth, Markus},
title = {T 1 ‐weighted fMRI in mouse visual cortex using an iron oxide nanoparticle contrast agent and UTE imaging at 9.4 T},
journal = {Magnetic Resonance in Medicine},
year = {2026},
doi = {10.1002/mrm.70103}
}
EUVIMED